Rheumatological Diseases: A Growing Health Crisis Affecting Millions in Europe and Beyond
Table of Contents
Rheumatological diseases represent a significant and often underestimated health challenge, impacting an estimated 6 million people in Italy alone and standing as the leading cause of pain and disability across Europe, according to the World Health Organization. These conditions, encompassing over 150 distinct diseases, can severely impair daily life, from simple tasks like getting out of bed to maintaining employment. Increased awareness and early diagnosis are crucial to mitigating their impact.
The Invisible Burden of Chronic Pain
For many, living with a rheumatological disease is an ongoing obstacle course. Individuals struggle with basic activities – standing for extended periods, tying shoes, or even working – all while enduring persistent pain. These diseases affect people of all ages, including children, and range in severity from manageable to debilitating. Common conditions include osteoarthritis, osteoporosis, rheumatoid arthritis, and fibromyalgia, alongside rarer and more serious illnesses like Systemic Sclerosis (scleroderma), lupus erythematosus, and Sjögren’s syndrome. World Rheumatological Disease Day, observed annually on October 12th, aims to spotlight the suffering of those affected and promote greater understanding.
Debunking Myths and Understanding the Scope
Despite their prevalence, rheumatological diseases remain widely misunderstood. As Dr. Andrea Doria, president of the Italian Society of Rheumatology (SIR), explains, there’s a common misconception that these conditions only affect the elderly. “Actually they can also affect young adults in the midst of their active life, women of reproductive age, children,” he stated. Another pervasive myth is that these diseases are “inevitable.” While genetics play a role, Dr. Doria emphasizes that preventative measures are possible. Adopting healthy habits – avoiding smoking, maintaining a balanced diet, exercising regularly, maintaining a healthy weight, and receiving vaccinations – can reduce the risk of developing these conditions or delay their onset, particularly for those with a family history. Family members of patients, in fact, have a 10% increased risk of developing a rheumatological disease.
A Spectrum of Diseases with Diverse Impacts
Rheumatological diseases are incredibly diverse, varying in risk factors, underlying mechanisms, affected populations, symptoms, treatments, and potential complications. They are broadly categorized as follows:
- Degenerative diseases, such as osteoarthritis, linked to the natural aging process.
- Inflammatory diseases, including various forms of arthritis (rheumatoid, psoriatic, etc.) and spondyloarthritis, caused by chronic inflammation primarily affecting the joints.
- Systemic autoimmune diseases – conditions where the immune system mistakenly attacks the body’s own tissues, impacting multiple organs.
- Metabolic diseases, like gout, resulting from metabolic imbalances that lead to harmful substance accumulation.
The Critical Importance of Early Diagnosis
Early diagnosis is paramount in managing rheumatological diseases, yet it often remains delayed. Gian Domenico Sebastiani, past president of the Italian Society of Rheumatology (SIR), notes that, on average, it takes seven years to diagnose psoriatic arthritis, five years for ankylosing spondylitis, three years for systemic sclerosis, and two years for arthritis. This delay can lead to irreversible damage, incurring substantial health and social costs – including pharmacological treatments, hospitalizations, rehabilitation, lost workdays, and disability benefits. Rheumatoid arthritis alone carries an annual cost exceeding 2 billion euros in Italy.
Recognizing the Warning Signs
Several warning signs should prompt a medical evaluation. These include:
- Nighttime or resting pain accompanied by joint swelling and morning stiffness.
- Persistent chronic fatigue.
- Ongoing joint and muscle pain.
- Raynaud’s phenomenon – cold fingers changing color from white to bluish to red upon exposure to temperature changes.
- Symptoms of dry eye or dry mouth.
Individuals experiencing one or more of these symptoms should consult their family doctor, who can then recommend diagnostic tests or a referral to a rheumatologist.
Advances in Treatment and the Promise of Remission
Fortunately, advancements in research have led to treatments capable of controlling many rheumatological diseases and even achieving remission. Roberto Caporali, president-elect of SIR, explains that the pharmacological landscape has significantly expanded in the last 15 years due to a deeper understanding of the underlying mechanisms. “Today the new frontier is called ‘personalized medicine’ and consists in trying to define the right drug, for the right patient, at the right time,” he said. This approach involves biomarker analysis and tissue analysis to identify the most effective treatment for each individual, minimizing ineffective therapies.
The Italian Society of Rheumatology is advocating for concrete action to address this health emergency, including prevention and awareness campaigns, early diagnosis initiatives, equitable access to innovative therapies, strengthened telemedicine and multidisciplinary care, and enhanced training for healthcare professionals.
New Research Aims to Address Gaps in Knowledge
To further understand the landscape of rheumatological diseases in Italy, the National Association of People with Rheumatological and Rare Diseases (APMARR) and CREA Sanità are collaborating on a research project, “Rheumatological diseases in Italy: epidemiology and equity of access to care.” The project, to be presented in Rome on October 16th, will focus on bridging gaps in data regarding the prevalence and incidence of conditions like spondyloarthritis, lupus, and lupus nephritis. It will also collect data on patient expenses and quality of life, and monitor access to specialist services. Antonella Celano, president of APMARR, emphasizes the urgent need to address waiting lists for specialist appointments, stating, “In rheumatological pathologies it is important to be able to reach one early diagnosis and, for this reason, it is necessary that waiting lists are eliminated, otherwise people will never be able to have an early diagnosis or even appropriate treatment.” Ensuring equal access to care for all patients remains a critical goal.
October 11, 2025
© ALL RIGHTS RESERVED
